Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RCUS
#1597
Arcus Biosciences, Inc.
20.3
8
+4.57%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+4.57%
Variazione Mensile
-12.53%
Variazione di 6 mesi
+92.26%
Variazione Annuale
+96.53%
Chiusura Precedente
19.4
9
Open
20.1
5
Bid
Ask
Low
20.0
7
High
20.4
4
Volume
601
Mercati
Mercato Azionario Statunitense
Salute
RCUS
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
Notizie
Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
Arcus Biosciences, Inc. (RCUS) Q4 2025 Earnings Call Transcript
Presentazione Arcus 2025: i dati di casdatifan si rafforzano, emerge la pipeline I&I
Arcus 2025 presentation: casdatifan data strengthens, I&I pipeline emerges
Arcus Biosciences earnings beat by $0.21, revenue fell short of estimates
Arcus Biosciences in spotlight: Kidney drug trial results at stake
AMD, IBM among market cap stock movers on Tuesday